The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index; 33 of the 133 sources its claims cite were checked for support.
Neuroendocrine Disruptions Following Head Injury
Open accessAbstract
Purpose of review This article reviews hypopituitarism after TBI, the importance of pituitary hormones, and related controversies, concluding with a suggested patient approach. Recent findings While earlier studies focused on increased pituitary deficiencies after moderate-severe TBI, recent studies have focused on deficiencies after mild TBI. There has been increasing focus on the role of growth hormone after injury; growth hormone is the most frequent reported deficiency at 1 year post-TBI, and an area with unresolved questions. While more research is needed to quantify the risk of deficiencies in special populations, and establish the natural history, increasing data indicate an increase in hypopituitarism after other acquired brain injuries; the potential role of pituitary hormone deficiencies after stroke and after COVID-19 infection is an area of active inquiry. Given the negative health effects of untreated hypopituitarism and the opportunity to intervene via hormone replacement, it is important to recognize the role of pituitary hormone deficiencies after TBI.
Overview
CoChat Summary
TL;DR
This review summarizes evidence that traumatic brain injury, including mild and repetitive sports injury, increases the risk of chronic anterior pituitary hormone deficiencies that may appear delayed and can improve with hormone replacement. It emphasizes recognition, symptom-based screening, and unresolved controversies—especially around growth hormone deficiency diagnosis and treatment.
Key findings
- Chronic pituitary dysfunction is reported in 15–60% of adults after TBI and up to 42% of children/adolescents; using guideline-based definitions, anterior pituitary deficiencies approximate 25–30% by 1 year after TBI, versus <0.05% in one healthy adult population study.
- Deficiencies can develop late: in 70 adults evaluated at 3 and 12 months, 8% had more deficiencies at 12 months; in 58 children/adolescents assessed at 3, 6, and 12 months, 5 had new deficiencies at 12 months not present earlier.
- Mild TBI and repetitive sports injury confer risk: among retired NFL players, GHD was diagnosed in 41.2% (28/68) using standard cutoff and 19.1% (13/68) using BMI-adjusted thresholds; in 58 veterans evaluated in a pituitary clinic, GHD was 20.7% and adrenal insufficiency 22.4%.
- Acute neuroendocrine abnormalities are common but often transient: acute adrenal insufficiency rates range 9.8–78%, central DI/AVP-D 14–26%, and SIADH 2.5–14%; acute adrenal insufficiency does not correlate with chronic adrenal insufficiency.
Methods
- Narrative review of hypopituitarism after TBI, covering acute and chronic anterior pituitary deficiencies, posterior pituitary dysfunction, hormone replacement, controversies, and a suggested practical patient approach.
- Synthesizes published studies and guidelines; no primary cohort, systematic search, or meta-analysis is described.
- Includes tables summarizing hypothalamic-pituitary-end organ hormones, evaluation/replacement of anterior pituitary deficiencies, and guideline recommendations for post-TBI pituitary management.
Limitations
- Author-stated: exact incidence remains uncertain because reported rates vary by study design, cohort features, and hormone evaluation methods; GHD in particular has wide variation in test methodology and diagnostic thresholds.
- Author-stated: the mechanism by which TBI leads to pituitary deficiencies remains unknown; no clinically useful predictor has been identified, and acute pituitary dysfunction does not correlate with chronic deficiencies.
- Evident from text: as a narrative review, it provides no new primary data or systematic quantitative synthesis, and some recommendations reflect the author’s own practice in addition to cited guidelines.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
18 Valid · 16 Not valid · 25 Not checked · 23 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Limited evidence suggests a similar increase in hormone dysfunction following blast injury as well as non-blast TBI incurred during military service.”
What the sources say
- Partly supportedcites [44] Undurti A, et al. Chronic Hypopituitarism Associated with Increased Postconcussive Symptoms Is Prevalent after Blast-Induced Mild Traumatic Brain Injury. Front Neurol. 2018;9:72. https://doi.org/10.3389/fneur.2018.00072. sourceExperimental — accuracy not yet measured
The Abstract and Discussion report hormone dysfunction after blast-related TBI in military veterans, including positive screens in 12 of 39 veterans with blast-related concussion. The Discussion mentions a military TBI cohort that included some non-blast injuries, but reports only a pooled pituitary-abnormality rate; it does not establish a similar increase specifically after non-blast TBI incurred during military service. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Disputedcites [45] Baxter D, et al. Pituitary dysfunction after blast traumatic brain injury: The UK BIOSAP study. Ann Neurol. 2013;74(4):527–36. https://doi.org/10.1002/ana.23958. sourceExperimental — accuracy not yet measured
The Results report anterior pituitary dysfunction in 32.0% of soldiers with blast TBI versus 2.6% of non-blast controls. The Discussion says dysfunction was more prevalent after blast injury, not similarly increased in both groups; the non-blast controls were civilians, not people injured during military service. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [46] Ciarlone SL, et al. Neuroendocrine function and associated mental health outcomes following mild traumatic brain injury in OEF-deployed service members. J Neurosci Res. 2020;98(6):1174–87. https://doi.org/10.1002/jnr.24604. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“with reports of chronic pituitary dysfunction in 15-60% of adults after TBI [1-5]”
What the sources say
- Not checked — no full text of the sourcecites [1] Agha A, et al. Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clin Endocrinol (Oxf). 2004;60(5):584–91. https://doi.org/10.1111/j.1365-2265.2004.02023.x. source
- Disputedcites [2] Wagner AK, et al. Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI. Brain Inj. 2012;26(10):1226–42. https://doi.org/10.3109/02699052.2012.667594. sourceExperimental — accuracy not yet measured
The Introduction reports chronic hypopituitarism after TBI, but gives a prevalence range of 1.4–29%, not 15–60%. The paper therefore supports the general occurrence of chronic pituitary dysfunction, but states a contrary numerical range. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [3] Hannon MJ, et al. Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality. J Clin Endocrinol Metab. 2013;98(8):3229–37. https://doi.org/10.1210/jc.2013-1555. source
- Not checked — no full text of the sourcecites [4] Cohan P, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med. 2005;33(10):2358–66. https://doi.org/10.1097/01.ccm.0000181735.51183.a7. source
- Not checked — no full text of the sourcecites [5] Tanriverdi F, et al. High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J Clin Endocrinol Metab. 2006;91(6):2105–11. https://doi.org/10.1210/jc.2005-2476. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“a study of 43 patients 3 or more months following acute COVID-19 illness found definitive GHD in 20 patients (46.5%) [45].”
What the sources say
- Disputedcites [45] Baxter D, et al. Pituitary dysfunction after blast traumatic brain injury: The UK BIOSAP study. Ann Neurol. 2013;74(4):527–36. https://doi.org/10.1002/ana.23958. sourceExperimental — accuracy not yet measured
The Results (Patient Characteristics; page unavailable) describe 19 soldiers with blast traumatic brain injury and 39 with nonblast traumatic brain injury, not 43 patients recovering from COVID-19. The Discussion (page unavailable) reports three soldiers with growth hormone deficiency, not 20 patients (46.5%). (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainn = 20- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Even mild TBI confers an increased risk for chronic anterior pituitary hormone deficiencies, which may appear at a delay.”
- Also stated in: § Severity of Injury is Not a Good Predictor of Endocrine Dysfunction · p. 3 · boosted
“It is now clear that pituitary deficiencies are seen after mild TBI [17, 26 · ]”
What the sources say
- Partly supportedcites [17] Tanriverdi F, Kelestimur F. Pituitary dysfunction following traumatic brain injury: clinical perspectives. Neuropsychiatr Dis Treat. 2015;11:1835–43. https://doi.org/10.2147/NDT.S65814. sourceExperimental — accuracy not yet measured
The Frequency of TBI-induced chronic hypopituitarism section reports anterior hypopituitarism after mild TBI, but specifies that the mild cases in the cited meta-analysis required hospitalization and neurosurgical intervention; it also reports a rate below 1% in a largely mild, unselected emergency-department population. The Screening strategy during chronic phase section describes possible new-onset deficiencies during follow-up after complicated mild TBI. The claim omits that qualification and extends the finding to mild TBI generally. (LLM, conf=0.88)
- Not checked yetcites [26] Yuen KCJ, et al. A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury. Growth Horm IGF Res. 2022;66:101495. https://doi.org/10.1016/j.ghir.2022.101495. These recent multidisciplinary statements discuss the evaluation and management of growth hormone deficiency in children and adults following mild TBI, highlighting some of the specific barriers in appropriate care for patients. source
Checked before — its earlier verdict is held back until a new check runs.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Severity of Injury is Not a Good Predictor of Endocrine Dysfunction · p. 3 · boosted
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“More recently, a study of 58 children and adolescents assessed at 3, 6, and 12 months after TBI found new hormonal deficiencies in 5 subjects at 12 months that were not present at 3 and 6 months [19].”
What the sources say
- Partly supportedcites [19] Krahulik D, et al. Prospective study of hypothalamo-hypophyseal dysfunction in children and adolescents following traumatic brain injury. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(1):80–5. https://doi.org/10.5507/bp.2016.047. sourceExperimental — accuracy not yet measured
The Methods and Results describe 58 children and assessments at 3, 6, and 12 months after TBI. The Results report two GH deficiencies and two cases of partial hypogonadotropic hypogonadism at 12 months, plus central hypothyroidism in a boy who already had GH deficiency at 6 months. Thus the paper does not support five subjects with new deficiencies absent at both earlier assessments. (LLM, conf=0.90)
plainn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
41 more claims · 13 with their cited sources checked
Create a free account to see all 82 claims and to verify the 5 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 21
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Issues, Trends, and Controversies · p. 7
“a study of 43 patients 3 or more months following acute COVID-19 illness found definitive GHD in 20 patients (46.5%) [45].”
§ References · p. 11
“45. Baxter D, et al. Pituitary dysfunction after blast traumatic brain injury: The UK BIOSAP study.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Epidemiology · p. 2
“This stands in sharp contrast to the < 0.05% prevalence found in the one study of pituitary deficiencies in a healthy adult population [10].”
§ References · p. 10
“10. Klose M, et al. Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Issues, Trends, and Controversies · p. 7
“Downregulation of genes involved in GH has been described in postmortem studies of patients who died from COVID-19 [44]”
§ References · p. 11
“44. Undurti A, et al. Chronic Hypopituitarism Associated with Increased Postconcussive Symptoms Is Prevalent after BlastInduced Mild Traumatic Brain Injury.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Issues, Trends, and Controversies · p. 7
“There is some evidence that pituitary hormone dysfunction is seen at increased rates after subarachnoid hemorrhage and ischemic stroke, though definitions of deficiencies in this literature vary [39-43].”
§ References · p. 11
“39. Tanriverdi F, et al. Hypopituitarism due to sports related head trauma and the effects of growth hormone replacement in retired amateur boxers.”
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
American Medical Society for Sports Medicine position statement on concussion in sport
Harmon, K. G., Clugston, J. R., Dec, K., Hainline, B., Herring, S., Kane, S. F., Kontos, A. P., Leddy, J. J., McCrea, M., Poddar, S. K., et al. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100338 · Cited by 482
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study
Aimaretti, G., Ambrosio, M. R., Di Somma, C., Gasperi, M., Cannavò, S., Scaroni, C., Fusco, A., Del Monte, P., De Menis, E., Faustini-Fustini, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0504 · Cited by 370
Tanriverdi, F., Senyurek, H., Unluhizarci, K., Selcuklu, A., Casanueva, F. F., & Kelestimur, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2476 · Cited by 336
Occurrence of pituitary dysfunction following traumatic brain injury
Bondanelli, M., De Marinis, L., Ambrosio, M. R., Monesi, M., Valle, D., Zatelli, M. C., Fusco, A., Bianchi, A., Farneti, M., & Degli, E. C. I. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041269713 · Cited by 322
Neuroendocrine dysfunction in the acute phase of traumatic brain injury
Agha, A., Rogers, B., Mylotte, D., Taleb, F., Tormey, W., Phillips, J., & Thompson, C. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02023.x · Cited by 313
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Cited by
Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives
Aghili, Z. S., Khoshnevisan, G., Mostoli, R., Alibaglouei, M., & Zarkesh‐Esfahani, S. H. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10304-w · Cited by 19
Heart Rate Variability and Autonomic Dysfunction After Stroke: Prognostic Markers for Recovery
Lago, S., de Beukelaar, T. T., Casetta, I., Arcara, G., & Mantini, D. (2025) · Biomedicines · doi:10.3390/biomedicines13071659 · Cited by 18
“Several key factors contribute to these changes in autonomic regulation, including damage to the central nervous system [41,42], inflammatory responses [43,44], and neuroendocrine disruptions [45,46].”
Endocrine dysfunction post-traumatic brain injury: challenges and therapeutic approaches
Soltani, Z. E., Nazari, M., Babaei, M., Shakeri, H., Jalali, S., Hajali, V., & Keshavarzi, Z. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02755-6 · Cited by 9
Rhind, S. G., Shiu, M. Y., Vartanian, O. A., Tenn, C. C., Nakashima, A., Jetly, R., Yang, Z., & Wang, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413683 · Cited by 7
Hasan, S., & Uff, C. E. G. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102006 · Cited by 7
Metadata
- Authors
- Wexler, T. L.
- Affiliations
- NYU Langone Health (US)
- Corresponding author
- Wexler, Tamara L.
- ORCID
- Wexler, Tamara L.
- Venue
- Current Neurology and Neuroscience Reports
- Published
- 2023-05
- Volume
- 23
- Issue
- 5
- Pages
- 213-224
- ISSN
- 1528-4042 (ISSN-L)
- 1534-6293
- PMC
- PMC10163581
- OpenAlex
- W4372346066
- Semantic Scholar
- ed7271665160707175809682082651404d12d6c7
- Cited by
- 23
- References
- 71
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 8 · 2023: 1
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Current Neurology and Neuroscience Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- hypopituitarism, traumatic brain injury, mild traumatic brain injury, growth hormone deficiency, pituitary hormones, acquired brain injury, stroke, COVID-19 pandemic, hormone replacement therapy, neuroendocrine disruption
- MeSH terms
- COVID-19, Brain Injuries, Humans, Hypopituitarism, Growth Hormone, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroendocrine Disruptions Following Head Injury. https://app.cochat.ai/papers/10.1007/s11910-023-01263-5
- The paper
- Wexler, T. L. (2023). Neuroendocrine Disruptions Following Head Injury. Current Neurology and Neuroscience Reports. https://doi.org/10.1007/s11910-023-01263-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.